U.S. Markets closed

Company News For Jan 2, 2020

Zacks Equity Research
  • Shares of Neovasc Inc. NVCN soared nearly 37% after the company announced that it had submitted a premarket approval application to the U.S. Food and Drug Administration for Neovasc Reducer, used in treatment of refractory angina
  • Shares of Viveve Medical, Inc. VIVE jumped 46.5% after the company announced that it has regained compliance with Nasdaq listing rules
  • Shares of Seadrill Limited SDRL rose 7.2% after the company reported that it has received a 3-year contract for AOD II and AOD III, which is expected to be $98 million and $101 million in value
  • Shares of Urovant Sciences Ltd. UROV rose 18.4% after the company reported submission of New Drug Application for Vibegron, used for the treatment of overactive bladder


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Neovasc Inc. (NVCN) : Free Stock Analysis Report
 
Viveve Medical, Inc. (VIVE) : Free Stock Analysis Report
 
Urovant Sciences Ltd. (UROV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research